{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:26:17Z","timestamp":1786994777473,"version":"build-2736575974"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"name":"Spanish Ministry of Economy and Competitiveness ISCIII"},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004587","name":"ISCIII","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.neurobiolaging.2015.10.022","type":"journal-article","created":{"date-parts":[[2015,11,4]],"date-time":"2015-11-04T09:11:48Z","timestamp":1446628308000},"page":"47-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["CSF YKL-40 and pTau181 are related to different cerebral morphometric patterns in early AD"],"prefix":"10.1016","volume":"38","author":[{"given":"Juan Domingo","family":"Gispert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma C.","family":"Mont\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Falcon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Tucholka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Rojas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"S\u00e1nchez-Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Antonell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Llad\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Rami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Molinuevo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib1","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3233\/JAD-140240","article-title":"Relationship between beta-secretase, inflammation and core cerebrospinal fluid biomarkers for Alzheimer's disease","volume":"42","author":"Alcolea","year":"2014","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib3","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.neurobiolaging.2015.03.001","article-title":"Relationship between cortical thickness and cerebrospinal fluid YKL-40 in predementia stages of Alzheimer's disease","volume":"36","author":"Alcolea","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib4","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00702-010-0534-0","article-title":"Different profiles of Alzheimer's disease cerebrospinal fluid biomarkers in controls and subjects with subjective memory complaints","volume":"118","author":"Antonell","year":"2011","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib5","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3233\/JAD-140624","article-title":"Cerebrospinal fluid level of YKL-40 protein in preclinical and prodromal Alzheimer's disease","volume":"42","author":"Antonell","year":"2014","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neuroimage.2007.07.007","article-title":"A\u00a0fast diffeomorphic image registration algorithm","volume":"38","author":"Ashburner","year":"2007","journal-title":"Neuroimage"},{"issue":"6 Pt 1","key":"10.1016\/j.neurobiolaging.2015.10.022_bib7","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1006\/nimg.2000.0582","article-title":"Voxel-based morphometry\u2014the methods","volume":"11","author":"Ashburner","year":"2000","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib8","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.neuroimage.2005.02.018","article-title":"Unified segmentation","volume":"26","author":"Ashburner","year":"2005","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib9","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1750-3639.2011.00550.x","article-title":"Astrocyte and macrophage regulation of YKL-40 expression and cellular response in neuroinflammation","volume":"22","author":"Bonneh-Barkay","year":"2012","journal-title":"Brain Pathol."},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib10","doi-asserted-by":"crossref","first-page":"130","DOI":"10.2353\/ajpath.2008.080045","article-title":"YKL-40, a marker of simian immunodeficiency virus encephalitis, modulates the biological activity of basic fibroblast growth factor","volume":"173","author":"Bonneh-Barkay","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib11","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1097\/NEN.0b013e31826eaee7","article-title":"Exacerbation of experimental autoimmune encephalomyelitis in the absence of breast regression protein 39\/chitinase 3-like 1","volume":"71","author":"Bonneh-Barkay","year":"2012","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1742-2094-7-34","article-title":"In\u00a0vivo CHI3L1 (YKL-40) expression in astrocytes in acute and chronic neurological diseases","volume":"7","author":"Bonneh-Barkay","year":"2010","journal-title":"J.\u00a0Neuroinflammation"},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib13","series-title":"Model selection and multimodel inference: a practical information-theoretic approach","author":"Burnham","year":"2002"},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib14","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2967\/jnumed.110.087031","article-title":"Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG","volume":"53","author":"Carter","year":"2012","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib15","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1007\/s00259-014-2859-7","article-title":"Astrocytosis measured by 11C-deprenyl PET correlates with decrease in gray matter density in the parahippocampus of prodromal Alzheimer's patients","volume":"41","author":"Choo","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib16","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.biopsych.2010.08.025","article-title":"YKL-40: a novel prognostic fluid biomarker for preclinical Alzheimer's disease","volume":"68","author":"Craig-Schapiro","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib17","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer's disease: the IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.31887\/DCNS.2009.11.2\/bdubois","article-title":"Early detection of Alzheimer's disease: new diagnostic criteria","volume":"11","author":"Dubois","year":"2009","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib19","doi-asserted-by":"crossref","first-page":"142","DOI":"10.2174\/156720511795256080","article-title":"The early involvement of the innate immunity in the pathogenesis of late-onset Alzheimer's disease: neuropathological, epidemiological and genetic evidence","volume":"8","author":"Eikelenboom","year":"2011","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib20","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.biopsych.2011.02.017","article-title":"Cognitively preserved subjects with transitional cerebrospinal fluid ss-amyloid 1-42 values have thicker cortex in Alzheimer's disease vulnerable areas","volume":"70","author":"Fortea","year":"2011","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib21","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1016\/j.neurobiolaging.2015.06.027","article-title":"Nonlinear cerebral atrophy patterns across the Alzheimer's disease continuum: impact of APOE4 genotype","volume":"36","author":"Gispert","year":"2015","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib22","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.neurobiolaging.2011.02.012","article-title":"Alzheimer's disease markers, hypertension, and gray matter damage in normal elderly","volume":"33","author":"Glodzik","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib23","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/S1474-4422(15)70016-5","article-title":"Neuroinflammation in Alzheimer's disease","volume":"14","author":"Heneka","year":"2015","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib24","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jalz.2011.03.004","article-title":"Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Jack","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib25","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.neuroimage.2008.12.037","article-title":"Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration","volume":"46","author":"Klein","year":"2009","journal-title":"NeuroImage"},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3233\/JAD-130203","article-title":"The AD-CSF-index discriminates Alzheimer's disease patients from healthy controls: a validation study","volume":"36","author":"Molinuevo","year":"2013","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib27","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/j.neurobiolaging.2013.02.013","article-title":"Different patterns of gray matter atrophy in early- and late-onset Alzheimer's disease","volume":"34","author":"Moller","year":"2013","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JAD-2012-120787","article-title":"Microglial markers are elevated in the prodromal phase of Alzheimer's disease and vascular dementia","volume":"33","author":"Olsson","year":"2013","journal-title":"J.\u00a0Alzheimers Dis."},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib29","doi-asserted-by":"crossref","first-page":"e16032","DOI":"10.1371\/journal.pone.0016032","article-title":"Identification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's disease","volume":"6","author":"Perrin","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib30","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.neuroimage.2011.11.075","article-title":"Brain imaging in the study of Alzheimer's disease","volume":"61","author":"Reiman","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib31","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/0006-291X(88)90524-4","article-title":"Isolation and characterization of a novel 39 kilodalton whey protein from bovine mammary secretions collected during the nonlactating period","volume":"150","author":"Rejman","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib32","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1159\/000362164","article-title":"Increased levels of chitotriosidase and YKL-40 in cerebrospinal fluid from patients with Alzheimer's disease","volume":"4","author":"Rosen","year":"2014","journal-title":"Dement. Geriatr. Cogn. Dis. Extra"},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib33","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.biopsych.2012.11.028","article-title":"Resting state functional connectivity in preclinical Alzheimer's disease","volume":"74","author":"Sheline","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib34","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib35","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/jamaneurol.2015.1285","article-title":"Longitudinal cerebrospinal fluid biomarker changes in preclinical Alzheimer disease during middle age","volume":"72","author":"Sutphen","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib36","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1001\/jamaneurol.2015.0202","article-title":"Cerebrospinal fluid markers of neurodegeneration and rates of brain atrophy in early Alzheimer disease","volume":"72","author":"Tarawneh","year":"2015","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib37","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00401-008-0366-2","article-title":"Cerebral amyloid angiopathy and its relationship to Alzheimer's disease","volume":"115","author":"Thal","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib38","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.jalz.2014.08.105","article-title":"Imaging neuroinflammation in Alzheimer's and other dementias: recent advances and future directions","volume":"11","author":"Varley","year":"2014","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.neurobiolaging.2015.10.022_bib39","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/neup.12158","article-title":"Role for mammalian chitinase 3-like protein 1 in traumatic brain injury","volume":"35","author":"Wiley","year":"2015","journal-title":"Neuropathology"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458015005345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458015005345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:25:10Z","timestamp":1759317910000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458015005345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":39,"alternative-id":["S0197458015005345"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.10.022","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CSF YKL-40 and pTau181 are related to different cerebral morphometric patterns in early AD","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2015.10.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}